What is NDC 76420-220?

76420-220 is the product NDC for Triloan SUIK (triamcinolone acetonide), Triamcinolone acetonide 40 mg/mL injection, suspension, listed with the FDA by Asclemed USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Triloan SUIK (Triamcinolone Acetonide).

Asclemed USA, Inc., NDC labeler code 76420. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Triloan SUIK?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Triloan SUIK NDC 76420-220 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)76420-220Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76420-0220Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76420-220-01	7642002200176420022001	1 VIAL, SINGLE-DOSE in 1 CARTON (76420-220-01) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Jun 1, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triloan SUIK
Generic name (nonproprietary): triamcinolone acetonide
Active ingredients: Triamcinolone acetonide — 40 mg/mL
Dosage form: Injection, Suspension
Route: Intra-articular, Intramuscular
Labeler: Asclemed USA, Inc.NDC labeler code 76420
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jun 1, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 76420-220_df6aa318-eae8-608c-e053-2995a90a0d27SPL ID df6aa318-eae8-608c-e053-2995a90a0d27SPL set ID 320f7f0c-177c-42dc-96e6-4d688677c57aUNII F446C597KA
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N476420022001 followed by a unit qualifier and the quantity

Package 76420-0220-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 20, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 76420-220

What is NDC 76420-220?: 76420-220 is the product NDC for Triloan SUIK (triamcinolone acetonide), Triamcinolone acetonide 40 mg/mL injection, suspension, listed with the FDA by Asclemed USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Triloan SUIK (Triamcinolone Acetonide).
What is the active ingredient?: Triamcinolone acetonide.
Who is the labeler?: Asclemed USA, Inc., NDC labeler code 76420. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Triloan SUIK?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Triloan SUIK (Triamcinolone acetonide) NDC 76420-220